US2014114350A1PendingUtilityA1
Wound closure device
Est. expiryOct 8, 2029(~3.2 yrs left)· nominal 20-yr term from priority
Inventors:Timothy SargeantGregory FischvogtMichael J. BettuchiGerald HodgkinsonJoshua StopekArpan DesaiAtu AgawuSaumya Banerjee
A61B 17/0057A61L 31/148A61B 2017/00637A61L 31/145A61F 2/0063A61B 2017/00884A61B 2017/00898
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Biocompatible wound closure devices including an elongate body and a plug member are useful for wound repair.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A wound closure device comprising:
an elongate body having a proximal end and a distal end, the elongate body formed from a hydrogel and; a plug member coupled to the distal end of the elongate body, the plug member fabricated from a porous material.
22 . The wound closure device of claim 21 , wherein the elongate body includes a grooved exterior surface.
23 . The wound closure device of claim 21 , wherein the elongate body has a length of about 10 mm to about 150 mm.
24 . The wound closure device of claim 21 , wherein the hydrogel is bioabsorbable.
25 . The wound closure device of claim 21 , wherein the hydrogel is formed from multiple precursors.
26 . The wound closure device of claim 21 , wherein the hydrogel is formed from a single precursor.
27 . The wound closure device of claim 21 , wherein the hydrogel is activated by an environmental condition selected from the group consisting of temperature, pressure, pH, ionic strength, and combinations thereof.
28 . The wound closure device of claim 21 , wherein the plug member comprises a mesh.
29 . The wound closure device of claim 21 , wherein the plug member includes at least one reactive group that bonds to tissue.
30 . The wound closure device of claim 29 , wherein the at least one reactive group is selected from the group consisting of isocyanates, N-hydroxy succinimides, cyanoacrylates, aldehydes, genipin, trilysine, tetralysine, polylysines, diimides, diisocyanates, cyanamides, carboiimides, dimethyl adipimidate, starches, and combinations thereof.
31 . The wound closure device of claim 28 , wherein the mesh is bioabsorbable.
32 . The wound closure device of claim 29 , wherein the at least one reactive group is provided as a coating.
33 . The wound closure device of claim 32 , wherein the coating is in dry form.
34 . A wound closure device comprising:
an elongate body formed from a hydrogel; and a plug member attached to the elongate body and formed from a mesh including a tissue facing surface defining a diameter that is larger than a diameter of the elongate body.
35 . The wound closure device of claim 34 , wherein the hydrogel has a grooved exterior surface.
36 . The wound closure device of claim 34 , wherein the mesh includes at least one reactive group on the tissue facing surface.Join the waitlist — get patent alerts
Track US2014114350A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.